Ryan C. Heniford/LinkedIn
Oct 14, 2025, 05:26
Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
Ryan C. Heniford, Director of Global Business Development and Technical Marketing at Evonik, shared a post on LinkedIn:
”Today is World Thrombosis Day! A reminder that thrombosis prevention isn’t just about medication, it’s also about smarter medical devices.
That’s where Evonik’s Endexo technology comes in.
It’s an innovative passive surface modification that makes catheter surfaces inherently more biocompatible — no coatings, no drugs, no leaching.
Key benefits at a glance:
- Up to 99 % reduction in thrombus accumulation
- Less protein and platelet adhesion → reduced clot risk
- Lower friction for smoother handling and less trauma
- Durable performance because Endexo® is part of the polymer itself
On World Thrombosis Day, it’s worth remembering that every thrombus prevented is a patient protected — and that innovation in materials science plays a crucial role in that.”
Stay updated with Hemostasis Today.
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit
-
Jul 20, 2026, 21:15Leonie Bolt: Honored to Present on Coronary Artery Calcium Scoring in Hemophilia A at ISTH 2026
-
Jul 20, 2026, 21:12Mihir Jain: Can Gene Therapy Transform Hemophilia Care in India?
-
Jul 20, 2026, 21:10Mohammed W. Badri: Are We Doing Enough to Prevent Life-Threatening Bleeds in Children?